Malignancies associated with immunosuppressive or cytotoxic therapy.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D007680:Kidney Neoplasms; D016030:Kidney Transplantation; D007938:Leukemia / Q000628:therapy; D008048:Lip Neoplasms / Q000209:etiology; D016031:Liver Transplantation; D016403:Lymphoma, Large B-Cell, Diffuse / Q000209:etiology; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000139:chemically induced* / Q000601:surgery; D011183:Postoperative Complications; D012878:Skin Neoplasms / Q000209:etiology; D014019:Tissue Donors; D014184:Transplantation, Homologous / Q000009:adverse effects; D002583:Uterine Cervical Neoplasms / Q000209:etiology
D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents